Hypertension (High Blood Pressure) News and Research

RSS

Hypertension (or high blood pressure) is a condition where the pressure of the blood flowing through the arteries of the body is higher than it should be. Much like the pressure of the air in a tire, if the pressure of the blood is too high it can damage the arteries and organs of the body. Just like the tire, if the pressure suddenly becomes very high, catastrophic events can happen. Similarly, if the pressure remains somewhat elevated for a long enough period of time, premature wear and failure can occur.

Hypertension has its worst effects on the heart, kidneys, eyes, and brain. High blood pressure is a risk factor for heart attack, stroke, kidney failure, hemorrhages of the retina of the eye, and generalized atherosclerosis (hardening of the arteries all over the body).

Variability in SBP portends cognitive decline

Findings from the Ohasama study reveal an association between variability in home systolic blood pressure and cognitive decline.

14 Apr 2014

Loyola University Medical Center designated as Comprehensive Hypertension Center

Loyola University Medical Center has been approved as a Comprehensive Hypertension Center by the American Society of Hypertension. This designation recognizes centers that have demonstrated the highest level of expertise in treating patients with complex hypertension and co-existing medical conditions such as diabetes and chronic kidney disease.

11 Apr 2014

Snack food with olestra speeds up removal of toxins in body

According to a clinical trial led by University of Cincinnati researchers, a snack food ingredient called olestra has been found to speed up the removal of toxins in the body.

10 Apr 2014

Mayo Clinic research shows RA patients more likely to develop chronic kidney disease

Rheumatoid arthritis patients are likelier than the average person to develop chronic kidney disease, and more severe inflammation in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity are among the risk factors, new Mayo Clinic research shows.

10 Apr 2014

Studies provide evidence to clarify role of NAFLD as independent risk factor for development of CVD

Two new studies presented today at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the development of cardiovascular disease (CVD).

10 Apr 2014

Study describes how overeating causes brown fat cells to "whiten"

Boston University researchers have learned new information about the consequences of overeating high-calorie foods. Not only does this lead to an increase in white fat cell production, the type prominent in obesity, but it also leads to the dysfunction of brown fat cells, the unique type of fat that generates heat and burns energy.

10 Apr 2014

Children exposed to 'green exercise' more likely to experience health-enhancing effects after activity

Children who are exposed to scenes of nature while exercising are more likely to experience health-enhancing effects after activity, according to a Coventry University study published this week in the International Journal of Environmental Research and Public Health.

8 Apr 2014

Researchers discover hotspot L205R mutation is closely associated with adrenocortical tumors

Chinese researchers from Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, BGI, and other institutions have discovered that the activating hotspot L205R mutation in PRKACA gene was closely associated with adrenocortical tumors (ACTs), and the relationship of recurrently mutated DOT1L and CLASP2 with ACTs' other subtypes.

7 Apr 2014

Kidney disease patients with poor quality of life at increased risk of developing heart problems

Kidney disease patients with poor quality of life are at increased risk of experiencing progression of their disease and of developing heart problems, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings suggest that quality of life measurements may have important prognostic value in these individuals.

4 Apr 2014

Eating watermelon reduces blood pressure in overweight individuals

Be sure to pick up a watermelon - or two - at your neighborhood farmers' market. It could save your life.

4 Apr 2014

Adherent Health announces results of 2014 Patient Preference Study

Adherent Health, LLC, a mobile health engagement advisory focused on medication safe-use, adherence, and health outcomes attainment, announced today the results of its 2014 Patient Preference Study which surveyed the mobile app behaviors and medication support preferences of 2,216 prescription-taking patients aged 18-65+.

3 Apr 2014

Recommended daily sodium intake harmful for health, study finds

A new study published in the American Journal of Hypertension finds evidence that the average daily sodium intake of most Americans is actually associated with better health outcomes than intake levels currently recommended by the CDC and major health departments, which are now being viewed by many in the scientific community as excessively and unrealistically low.

3 Apr 2014

Ablative Solutions’ Peregrine System Infusion Catheter receives FDA clearance

Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.

3 Apr 2014

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) describes cardiopulmonary arrest in a 27-week-old infant following administration of three sets of cyclopentolate 0.2%/phenylephrine 1% (Cyclomydril) eyedrops.

3 Apr 2014

Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Pregnancy-related mortality has increased over the last 25 years. Ten years ago the top three pregnancy-related mortality diagnoses were hemorrhage, preeclampsia, and embolism (includes thrombotic and amniotic).

2 Apr 2014

Ablative Solutions' Peregrine System Infusion Catheter receives FDA clearance

Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Peregrine System™ Infusion Catheter.

2 Apr 2014

Northwestern University awarded NIH grant to conduct phase III Parkinson's neuroprotective study

Tanya Simuni, M.D., medical director of Northwestern University's Parkinson's Disease and Movement Disorders Center, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson's disease.

2 Apr 2014

Bayer’s Adempas now available in the UK to treat patients with CTEPH

Adempas (riociguat) is available in the UK today as the first drug treatment for CTEPH, to treat adult patients with WHO Functional Class (FC) II to III with inoperable or persistent disease to improve exercise capacity.

1 Apr 2014

Rigorous blood pressure control could halve recurrent stroke risk

Ensuring that the blood pressure of stroke survivors is controlled at least three-quarters of the time may halve their risk of a recurrence, shows a secondary analysis of the VISP trial.

31 Mar 2014

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

EKOS Corporation, a BTG International group company, notes the presentation of the results of the SEATTLE II trial this afternoon at ACC.14, the 63rd Annual Scientific Session and Exposition of the American College of Cardiology in Washington, DC in the United States.

31 Mar 2014

Hypertension (High Blood Pressure) News and Research

Further Reading

Variability in SBP portends cognitive decline

Loyola University Medical Center designated as Comprehensive Hypertension Center

Snack food with olestra speeds up removal of toxins in body

Mayo Clinic research shows RA patients more likely to develop chronic kidney disease

Studies provide evidence to clarify role of NAFLD as independent risk factor for development of CVD

Study describes how overeating causes brown fat cells to "whiten"

Children exposed to 'green exercise' more likely to experience health-enhancing effects after activity

Researchers discover hotspot L205R mutation is closely associated with adrenocortical tumors

Kidney disease patients with poor quality of life at increased risk of developing heart problems

Eating watermelon reduces blood pressure in overweight individuals

Adherent Health announces results of 2014 Patient Preference Study

Recommended daily sodium intake harmful for health, study finds

Ablative Solutions’ Peregrine System Infusion Catheter receives FDA clearance

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Ablative Solutions' Peregrine System Infusion Catheter receives FDA clearance

Northwestern University awarded NIH grant to conduct phase III Parkinson's neuroprotective study

Bayer’s Adempas now available in the UK to treat patients with CTEPH

Rigorous blood pressure control could halve recurrent stroke risk

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News